All Pharma News
Alentis Appoints Alberto Toso Chief Scientific Officer

Alentis Appoints Alberto Toso Chief Scientific Officer
BUSINESSWIRE
29 Apr 2024
Share Share
William Pao Joins Alentis Therapeutics as Independent Board Member

William Pao Joins Alentis Therapeutics as Independent Board Member
BUSINESSWIRE
08 Jan 2024
Share Share
Alentis Therapeutics Expands Leadership Team

Alentis Therapeutics Expands Leadership Team
BUSINESSWIRE
06 Dec 2023
Share Share
Alentis Doses Progressive Glomerulonephritis Patient in Ph 2 Trial of Lixudebart

Alentis Doses Progressive Glomerulonephritis Patient in Ph 2 Trial of Lixudebart
BUSINESSWIRE
05 Dec 2023
Share Share
Alentis Therapeutics Doses First Patient in Phase 1/2 Clinical Trial of ALE.C04

Alentis Therapeutics Doses First Patient in Phase 1/2 Clinical Trial of ALE.C04
BUSINESSWIRE
16 Nov 2023
Share Share
Alentis Therapeutics Appoints Lung Experts Professors Tony Mok

Alentis Therapeutics Appoints Lung Experts Professors Tony Mok
BUSINESSWIRE
05 Oct 2023
Share Share
Alentis Therapeutics to Present at the (ERS) International Congress

Alentis Therapeutics to Present at the (ERS) International Congress
BUSINESSWIRE
29 Aug 2023
Share Share
Alentis Therapeutics Receives FDA Fast Track Designation for ALE.C04

Alentis Therapeutics Receives FDA Fast Track Designation for ALE.C04
BUSINESSWIRE
24 Aug 2023
Share Share
Alentis Therapeutics Appoints Luca Santarelli as Chairperson

Alentis Therapeutics Appoints Luca Santarelli as Chairperson
BUSINESSWIRE
29 Jun 2023
Share Share
Alentis Therapeutics Reports Positive Topline Results From Phase 1

Alentis Therapeutics Reports Positive Topline Results From Phase 1
BUSINESSWIRE
26 Apr 2023
Share Share